Insider Transactions Reported by 22 Insiders of Adaptive Biotechnologies Corp

Symbol
ADPT on Nasdaq
Location
Seattle, WA

Insiders trading volume in the past year

Adaptive Biotechnologies Corp executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
CHAD M. ROBINS CEO and Chairman, Director $40,288,348 -$14,331,516 -26% 05 Jan 2026
HARLAN S. ROBINS Chief Scientific Officer $20,094,809 -$2,178,445 -9.8% 06 Jan 2026
FRANCIS LO Chief People Officer $5,642,889 -$3,457,388 -38% 12 Jan 2026
SHARON BENZENO Chief Commercial Ofc Imm Med $5,000,928 -$10,668,195 -68% 04 Dec 2025
JULIE RUBINSTEIN President and COO $4,111,861 -$415,540 -9.2% 04 Mar 2025
Kyle Piskel Chief Financial Officer $3,899,466 -$3,361,924 -46% 12 Jan 2026
SUSAN BOBULSKY Chief Commercial Officer, MRD $2,423,721 -$181,641 -7% 04 Mar 2025
TYCHO PETERSON Chief Financial Officer $1,828,542 04 Mar 2024
PETER M. NEUPERT Director $1,584,065 -$70,500 -4.3% 10 Mar 2025
NITIN SOOD Chief Commercial Officer, MRD $887,157 07 Aug 2023
ROBERT HERSHBERG Director $747,552 -$769,758 -51% 10 Dec 2025
R. MARK ADAMS Chief Operating Officer $724,241 10 Apr 2023
Stacy L Taylor SVP and General Counsel $626,780 22 Aug 2024
KATEY EINTERZ OWEN Director $576,674 04 Mar 2025
Michael J. Pellini Director $553,339 04 Mar 2025
HENNING THORSEN SVP, Commercial Operations $120,022 17 May 2021
MICHELLE RENEE GRIFFIN Director $110,683 -$385,304 -78% 13 Mar 2025
Leslie Trigg Director $106,996 06 Mar 2023
Kevin T. Conroy Director $94,858 06 Mar 2023
Chad M. Cohen Chief Financial Officer $89,225 22 Dec 2021
LANCE BALDO Chief Medical Officer $70,916 08 Mar 2022
Jyoti Palaniappan SVP, Diagnostics, T-Detect $37,823 19 Jul 2021

Recent Insider Transactions by Companies or Individuals for Adaptive Biotechnologies Corp

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.